학술논문

Local S100A8 Levels Correlate With Recurrence of Experimental Autoimmune Uveitis and Promote Pathogenic T Cell Activity
Document Type
article
Source
Investigative Ophthalmology & Visual Science. 59(3)
Subject
Eye Disease and Disorders of Vision
Autoimmune Disease
Biotechnology
Aetiology
2.1 Biological and endogenous factors
Inflammatory and immune system
Analysis of Variance
Animals
Aqueous Humor
Blotting
Western
Calgranulin A
Cytokines
Enzyme-Linked Immunosorbent Assay
HMGB1 Protein
Immunosuppressive Agents
Quinolines
Rats
Rats
Inbred Lew
T-Lymphocytes
Uveitis
recurrent autoimmune uveitis
immune regulation
autoreactive T cells
damage-associated molecular patterns
S1008/9
HMGB1
Biological Sciences
Medical and Health Sciences
Ophthalmology & Optometry
Language
Abstract
PurposeTo investigate the role of damage-associated molecular patterns (DAMPs) in recurrent experimental autoimmune uveitis (EAU).MethodsRecurrent EAU was induced in Lewis rats by interphotoreceptor retinoid-binding protein (IRBP) R16-peptide specific T cells (tEAU). Aqueous humor and serum samples were kinetically collected and DAMPs examined by quantitative proteomics, Western blot analysis, and ELISA. tEAU rats were treated with S100 inhibitor paquinimod followed by disease evaluation. The functions of T effector cells and T regulatory cells (Tregs) were compared between treated and nontreated groups. The expression of costimulatory molecules on antigen-presenting cells was examined by flow cytometry.ResultsS100A8, but not high mobility group box 1 (HMGB1), in the eye was found to be correlated with intraocular inflammatory episodes. Administration of paquinimod significantly protected tEAU rats from recurrence. Treated tEAU rats had fewer R16-specific Th1 and Th17 cells, but increased numbers of Tregs. R16-specific T cells from treated tEAU rats into naïve recipients prevented induction of tEAU by R16-specific T cells from nontreated tEAU rats. Moreover, APCs from treated tEAU rats expressed higher levels of a negative costimulatory molecule, CD200R, and lower levels of CD80, CD86, and MHC class II molecules compared to APCs from nontreated tEAU rats. An opposite pattern of expression of these molecules was observed on APCs incubated in vitro with recombinant S100A8.ConclusionsOur data demonstrate a link between local expression of DAMPs and autoimmune responses, and suggest that complete S100A8/A9 blockade may be a new therapeutic target in recurrent autoimmune uveitis.